Mackenzie Financial’s Allergan plc AGN.PRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Hold
0
806
2017
Q3
Hold
0
594
2017
Q2
Hold
0
462
2017
Q1
Hold
0
573
2016
Q4
Sell
-458
Closed -$346K 578
2016
Q3
$376K Sell
458
-1,360
-75% -$1.18M ﹤0.01% 535
2016
Q2
$1.51M Buy
+1,818
New +$1.52M 0.01% 505
2016
Q1
Sell
-1,508
Closed -$1.55M 923
2015
Q4
$1.55M Sell
1,508
-505
-25% -$507K 0.01% 455
2015
Q3
$1.9M Buy
2,013
+264
+15% +$275K 0.01% 421
2015
Q2
$1.83M Buy
+1,749
New +$1.83M 0.01% 441

Other funds holding AGN.PRA

Mackenzie Financial's AGN.PRA Position: Q4 2017 in Review

Mackenzie Financial held its Allergan plc (AGN.PRA) position steady in Q4 2017 at 0 shares worth $169K. The position accounts for ﹤0.01% of the portfolio, ranked #806.

Mackenzie Financial first reported a position in AGN.PRA in Q2 2015 and has held it in 5 quarters since. The position peaked at $1.9M in Q3 2015. 90 funds tracked by Wall St. Rank hold AGN.PRA as of Q4 2017.

  • Mackenzie Financial held 0 shares of Allergan plc worth $169K as of Q4 2017.
  • Mackenzie Financial left its Allergan plc share count unchanged in Q4 2017.
  • Allergan plc made up ﹤0.01% of Mackenzie Financial's portfolio in Q4 2017, its #806 holding.
  • Mackenzie Financial first reported a position in Allergan plc in Q2 2015 and has held it in 5 quarters since.
  • Mackenzie Financial's Allergan plc position peaked at $1.9M in Q3 2015.
  • 90 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on Mackenzie Financial's 13F filing for Q4 2017, filed 13 Feb 2018.